• SENSEX 80,597.66
    57.75 (+0.07%)
  • BANKNIFTY 55,341.85
    160.40 (+0.29%)
  • Authum Invest
    2,496.00 1,333.00(%)
  • N S D L
    1,161.50 880.00(%)
  • Adani Energy Sol
    774.50 588.25(%)
  • Muthoot Finance
    2,799.00 2,799.00(%)
  • JSW Cement
    145.05 145.05(%)
  • Zinka Logistics
    525.00 248.25(%)
  • HBL Engineering
    787.50 787.50(%)
  • Newgen Software
    929.00 1,795.50(%)
  • Waaree Energies
    2,833.50 1,808.65(%)
  • Ola Electric
    43.00 157.53(%)
  • Anthem Bioscienc
    838.40 838.40(%)
  • Reliance Industr
    1,369.95 1,115.55(%)
  • Vishal Mega Mart
    155.45 155.45(%)
  • Rico Auto Inds
    93.24 127.70(%)
  • All Time Plastic
    322.15 322.15(%)
  • ICICI Bank
    1,431.00 1,494.10(%)
  • Kotak Mah. Bank
    1,975.60 1,679.10(%)
  • Suzlon Energy
    60.00 46.00(%)
  • Everest Kanto
    157.55 231.50(%)
  • TCS
    3,017.90 2,992.05(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Jeena Sikho Lifecare Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 76054.0
  • ISIN : INE0J5801029
659.75 99 (17.67%)
  • As on 14 Aug 2025 (EOD)

  • Today’s Low

    563.90

  • Today’s High

    669.70

  • Open

    564.00

  • Perv Close

    560.70

  • 52W Low

    241.00

  • 52W High

    669.70

Key Indicators

  • P/E(TTM)

    89.60

  • Mar.Cap (₹Cr.)

    8,200.74

  • Div & Yield %

    0.17

  • Book Value(₹)

    21.96

  • Debt-Equity Ratio

    17.67

  • AGM Date

    14-Aug-2025

  • EPS

    7.30

  • P/E Ratio

    89.60

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    8,200.74

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    24.86

  • BV (₹)

    22.00

  • Sales( ₹ in Cr.)

    469.07

  • NP (in Cr.)

    90.73

  • NP Var(%)

    34.0

  • Div%

    55.0

  • CPS (₹)

    8.00

  • EPS (₹)

    7.30

  • Traded Value (₹ in Lakhs)

    8,130.51

  • 52 Week High

    669.70

  • 52 Week Low

    241.00

  • Price BSE

    654.0

  • Price NSE

    660.00

  • Market Capital( in Cr.)

    8,130.51

  • P/C Ratio

    81.80

  • P/E Ratio

    89.60

  • Price Vs.BV

    7.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 324.41 203.90 146.45 135.81 94.42 105.82
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 324.41 203.90 146.45 135.81 94.42 105.82
Other Income 6.44 2.28 1.49 1.07 0.76 0.06
Stock Adjustments 3.08 -1.65 -3.52 -1.28 -2.10 10.05
Total Income 333.93 204.53 144.42 135.60 93.08 115.93
EXPENDITURE :            
Raw Materials 24.84 15.48 11.94 15.01 10.15 32.73
Power and Fuel Cost 4.76 2.35 1.07 1.11 0.76 0.68
Employee Cost 65.91 43.44 33.75 30.38 21.65 14.45
Other Manufacturing Expenses 5.80 3.49 1.29 1.06 0.76 0.30
Selling and Administration Expenses 127.36 85.23 75.96 69.56 48.08 56.95
Miscellaneous Expenses 5.81 5.94 0.76 0.45 0.37 0.14
Employee Benefit Expenses 65.91 43.44 33.75 30.38 21.65 14.45
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 234.48 155.92 124.77 117.59 81.77 105.25
Operating Profit 99.45 48.61 19.65 18.01 11.29 10.69
Interest 0.43 0.95 1.18 1.36 1.64 1.15
Gross Profit 99.02 47.66 18.47 16.65 9.65 9.54
Depreciation 5.10 3.13 3.31 2.46 1.94 1.21
Profit Before Tax 93.92 44.53 15.16 14.19 7.71 8.33
Current Tax 23.87 11.50 3.90 3.82 1.99 2.22
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.84 -0.72 -0.01 0.07 0.00 0.11
Reported Net Profit 69.21 33.74 11.27 10.29 5.73 6.00
Extraordinary Items 1.34 0.40 0.59 -0.10 0.00 0.00
Adjusted Net Profit 67.87 33.34 10.68 10.39 5.73 6.00
Adjustment below Net Profit -11.05 0.00 -10.00 -0.20 0.00 0.00
P & L Balance brought forward 58.68 24.94 23.66 13.57 7.90 1.90
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 2.76 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 114.08 58.68 24.94 23.66 13.63 7.90
Dividend 2.76 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 48.00 20.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 4.80 2.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 27.84 24.43 11.15 1,015.21 572.63 599.71
Earnings Per Share(Adj)-Unit Curr 5.57 2.71 - - - -
Book Value 77.33 91.09 36.15 2,362.31 1,372.83 800.20
Book Value(Adj)-Unit Curr 15.47 10.12 - - - -

Shareholding Pattern

  • Promoter Group

    63.53%

  • Public Share Holding

    36.47%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 78,970,500 63.53 78,970,500 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 78,970,500 63.53 78,970,500 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 7,443,450 5.99 7,443,450 14
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 225,000 0.18 225,000 2
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 7,668,450 6.17 7,668,450 16
2] Non Institution
Bodies Corporate 13,605,760 10.95 13,605,760 247
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 853,530 0.69 853,530 448
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 8,131,400 6.54 8,131,400 19
Individuals holding nominal share capital up to Rs. 1 lakh 13,246,395 10.66 13,246,395 6,384
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 1,824,695 1.47 1,824,695 362
Sub Total 37,661,780 30.30 37,661,780 7,460
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 124,300,730 100.00 124,300,730 7,482

Company Background

Jeena Sikho Lifecare LtdPharmaceuticals - Indian - Formulations

  • Jeena Sikho Lifecare Ltd
  • BSE Code : 76054.0
  • ISIN : INE0J5801029

  • Incorporation Year

    2017

  • Registered Office

    SCO 11 First Floor Kalgidhar
    Enclave Zirakpur, Mohali,
    Punjab-140604

  • Telephone

    01762-513185

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

  • Auditor

    KRA & Co

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Skyline Financial Services Pvt
    D-153/A 1st Flr ,
    Okhla Industrial Are,Phase-I
    Mumbai - New Delhi-110020

Jeena Sikho Lifecare Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Jeena Sikho 654.10 330.85 324.41 89.60 59.04
Abbott India 33,235.85 6,684.73 6,409.15 48.63 44.95
Astrazeneca Phar 8,291.10 1,756.92 1,716.29 179.07 32.94
P & G Health Ltd 6,287.40 944.52 934.17 34.72 40.23
Glaxosmi. Pharma 2,768.50 3,866.05 3,723.49 49.78 58.72
Cipla 1,563.75 20,029.57 19,044.85 23.37 21.40
Amrutanjan Healt 690.35 437.58 421.23 36.60 20.84
Fermenta Biotec. 359.00 442.21 430.53 11.91 17.61
Guj. Themis Bio. 355.35 174.19 169.82 86.88 44.82
Bliss GVS Pharma 168.95 703.42 667.20 25.25 9.16
Ambalal Sarabhai 33.83 19.33 4.04 31.32 2.10